SciClone Q4 Net Drops Steeply
The pharmaceutical company's bottom line drops by nearly $10 million.
4/1/2013
by
DailyFinance
SciClone to Restate Financial Statements
The "China-centric" pharmaceutical aims to correct accounting errors.
2/25/2013
by
DailyFinance